ClinicalTrials.gg
Sign In

Failure to Thrive clinical trials

The registry lists 84 studies for Failure to Thrive across more than 10 countries. 12 are recruiting or about to start. 46 of them are mainly about Failure to Thrive (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.

Get an email when these change. Save the Failure to Thrive studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
44
Status unknown
10
Active, not recruiting
7
Not yet recruiting
7
Terminated
7
Recruiting
5

Phase

Phase 3
12
Phase 2
4
Phase 4
3
Phase 1
3

Where

United States
30
Australia
5
Indonesia
5
United Kingdom
5
Germany
5
Italy
5

Who runs them

Assiut University (4) · Ascendis Pharma Endocrinology Division A/S (4) · Tampere University (3) · University of Virginia (3) · Universitas Airlangga (3) · Medical University of Vienna (3) · Brigham and Women's Hospital (2) · Columbia University (2)

What is being tested here

Drugs under test in Failure to Thrive studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Human Growth Hormone146
Lonapegsomatropin122
Mecasermin002
Lactobacillus reuteri001
Essential amino acid001
Moringa001
Somavaratan011
Glutathione001
Megestrol Acetate001
Megestrol001

Coming up

3phase 3 studies under way
6studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6

Who these studies take

Of the 5 Failure to Thrive studies recruiting now, 1 (20%) set no upper age limit and 4 (80%) stop at 75 or younger. 5 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (20%) take healthy volunteers.

Recruiting studies that take each age, of 5
AgeWomenMen
104 (80%)4 (80%)
182 (40%)2 (40%)
301 (20%)1 (20%)
401 (20%)1 (20%)
501 (20%)1 (20%)
651 (20%)1 (20%)
751 (20%)1 (20%)
851 (20%)1 (20%)

Across all 84 studies, recruiting or not: 83% stop at 75 or younger and 83% at 65; 93% take children; 4% are for women only and 0% for men only; 24% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Failure to Thrive studies take

Of 18 interventional studies with no phase under Failure to Thrive, half reached primary completion within 18 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase18 mo9–30 · 18 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 84. Browse all 84 → or search them.